Natco Pharma launches Pomalidomide capsules in the US
The estimated sales for Pomalidomide in the US for the year ending September 2025 was approximately $3.2 billion
The estimated sales for Pomalidomide in the US for the year ending September 2025 was approximately $3.2 billion